In multiple myeloma, BCMA is almost exclusively expressed on plasmablasts and plasma cells and is weakly detectable on some memory B cells committed to plasma cell differentiation and on plasmacytoid dendritic cells [147]. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.